The accreditors of this session require that you periodically check in to verify that you are still attentive. Please click the button below to indicate that you are.
15005
Satellite Symposia: Can You Master MASH Diagnosis and Management? A CME Jeopardy Activity
Date
May 3, 2025
Society: DDW
With the recent change in terminology to metabolic dysfunction-associated steatotic liver disease (MASLD) and MASH and the new cardiometabolic criteria, clinical practice has shifted to incorporate screening of more patients for MASLD/MASH. Employing NITs is essential to identifying patients at high risk for MASH and further disease progression, as well as for selecting patients for the first-ever approved MASH therapy, resmetirom. Cardiometabolic comorbidities are common in these patients, and clinicians must be prepared to manage them, often using GLP-1 RAs. After a didactic background on MASH, attendees will compete in a CME Jeopardy game. Teams will be led by Drs. Mazen Noureddin and Kymberly Watt and the game will be moderated by Dr. Sonal Kumar. Topics covered will include nuances of diagnosis and staging using NITs, selecting candidates for resmetirom, and optimal management strategies, such as GLP-1 RAs, for the management of common cardiometabolic comorbidities. Join us for this fun, exciting, and competitive program and see if you have what it takes to win! Information: ExchangeCME.com/group-events/MASHSanDiego Sonal Kumar, MD, MPH (Moderator) Director, General Gastroenterology and Hepatology Director, Innovative Center for Health and Nutrition in Gastroenterology (ICHANGE) Assistant Professor of Medicine Weill Cornell Medicine New York, New York Mazen Noureddin, MD, MHSc Professor of Medicine Sherrie and Alan Conover Center for Liver Disease & Transplantation J.C. Walter Jr. Transplant Center Houston Methodist Hospital Weill Cornell Medical College Houston, Texas Kymberly D. Watt, MD Professor of Medicine Medical Director, Living Donor Liver Transplant Program Consultant, Gastroenterology & Hepatology Mayo Clinic Rochester, Minnesota Target Audience The educational design of this activity addresses the needs of gastroenterology and hepatology MD, NP, and PA clinicians who manage patients with metabolic dysfunction-associated steatohepatitis (MASH). Physician Accreditation Statement Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physician Credit Designation Integritas designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The ANCC's Commission on Accreditation recognizes educational activities that are approved for AMA PRA Category 1 Credits™ by providers who are accredited by the ACCME to award credit to learners. This reciprocity agreement allows nurses and nurse practitioners to use AMA PRA Category 1 Credits™ as approved ANCC contact hours for license renewal. Supported by: Novo Nordisk Inc. Provided by: Integritas Communications.
With the recent change in terminology to metabolic dysfunction-associated steatotic liver disease (MASLD) and MASH and the new cardiometabolic criteria, clinical practice has shifted to incorporate screening of more patients for MASLD/MASH. Employing NITs is essential to identifying patients at high risk for MASH and further disease progression, as well as for selecting patients for the first-ever approved MASH therapy, resmetirom. Cardiometabolic comorbidities are common in these patients, and clinicians must be prepared to manage them, often using GLP-1 RAs. After a didactic background on MASH, attendees will compete in a CME Jeopardy game. Teams will be led by Drs. Mazen Noureddin and Kymberly Watt and the game will be moderated by Dr. Sonal Kumar. Topics covered will include nuances of diagnosis and staging using NITs, selecting candidates for resmetirom, and optimal management strategies, such as GLP-1 RAs, for the management of common cardiometabolic comorbidities. Join us for this fun, exciting, and competitive program and see if you have what it takes to win! Information: ExchangeCME.com/group-events/MASHSanDiego Sonal Kumar, MD, MPH (Moderator) Director, General Gastroenterology and Hepatology Director, Innovative Center for Health and Nutrition in Gastroenterology (ICHANGE) Assistant Professor of Medicine Weill Cornell Medicine New York, New York Mazen Noureddin, MD, MHSc Professor of Medicine Sherrie and Alan Conover Center for Liver Disease & Transplantation J.C. Walter Jr. Transplant Center Houston Methodist Hospital Weill Cornell Medical College Houston, Texas Kymberly D. Watt, MD Professor of Medicine Medical Director, Living Donor Liver Transplant Program Consultant, Gastroenterology & Hepatology Mayo Clinic Rochester, Minnesota Target Audience The educational design of this activity addresses the needs of gastroenterology and hepatology MD, NP, and PA clinicians who manage patients with metabolic dysfunction-associated steatohepatitis (MASH). Physician Accreditation Statement Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physician Credit Designation Integritas designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The ANCC's Commission on Accreditation recognizes educational activities that are approved for AMA PRA Category 1 Credits™ by providers who are accredited by the ACCME to award credit to learners. This reciprocity agreement allows nurses and nurse practitioners to use AMA PRA Category 1 Credits™ as approved ANCC contact hours for license renewal. Supported by: Novo Nordisk Inc. Provided by: Integritas Communications.
Credits
- Credits: None available.
